Log In
Print
BCIQ
Print
Print this Print this
 

GP-101

  Manage Alerts
Collapse Summary General Information
Company Genoa Pharmaceuticals Inc.
DescriptionAerosol formulation of pirfenidone, a small molecule inhibitor of proinflammatory cytokines such as tumor necrosis factor (TNF) alpha and IL-1 beta, and pro-fibrotic cytokines, including platelet derived growth factor (PDGF) and transforming growth factor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPulmonary fibrosis
Indication DetailsTreat idiopathic pulmonary fibrosis (IPF)
Regulatory Designation

U.S. - Orphan Drug (Treat idiopathic pulmonary fibrosis (IPF))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today